• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE FB TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE FB TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY Back to Search Results
Model Number 1506-00-002
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Code Adhesion(s) (1695)
Date of Event 06/17/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Primary operative notes (b)(6) 2017 indicate the patient received a left total knee replacement due to end stage osteoarthritis.The patella was not resurfaced, and competitor cement was utilized.The surgery was completed without indication of complication by the surgeon.Revision operative notes (b)(6) 2020 indicate the patient received a left total knee revision due to aseptic loosening.Upon entering the joint, it is indicated that scarring was removed.The tibial component was loose, interface not provided.The femoral and insert components were also revised without indication of product deficiency.Depuy products were implanted, the patella was resurfaced and competitor cement was utilized.The surgery was completed without indication of complication by the surgeon.Doi: (b)(6) 2017.Dor: (b)(6) 2020.Left knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE FB TIB BASE SZ 2 CEM
Common Device Name
ATTUNE IMPLANT : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key11154961
Report Number1818910-2021-00884
Device Sequence Number17113275
Product Code OIY
UDI-Device Identifier10603295042365
UDI-Public10603295042365
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K101433
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2025
Device Model Number1506-00-002
Device Catalogue Number150600002
Device Lot Number8213097
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/05/2021
Supplement Date Received by Manufacturer02/18/2021
Initial Report FDA Received Date01/12/2021
Supplement Report FDA Received Date02/19/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE PS FB INSRT SZ 4 8MM.; ATTUNE PS FEM LT SZ 4 NAR CEM.; STRYKER SIMPLEX BONE CEMENT.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
-
-